SLNO FY 2019 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$23M

Net Income

-$31M

EPS (Diluted)

$-15.78

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$825,000

Balance Sheet

Total Assets

$38M

Total Liabilities

$23M

Stockholders' Equity

$15M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$2M	-19.7%
Operating Income	-$23M	-$14M	-62.2%
Net Income	-$31M	-$13M	-130.8%